FDA authorizes first antiviral pills for COVID-19
Paxlovid is available by prescription only and should be initiated as soon as possible after testing positive for COVID and within 5 days of symptom onset.
Prescribers should be aware of the potential for significant drug interactions and contraindications for use with certain drugs. In addition, Paxlovid is not recommended in patients with severe kidney or severe liver impairment. In patients with moderate renal impairment, a reduced Paxlovid dose is needed. ■